Federal biotech commission calls for retooling of scientific research infrastructure

Taking stock of the drug industry, from the lab to the medicine chest

November 25, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Scott Olson/Getty Images STAT+ | Federal biotech commission calls for retooling of scientific research infrastructure A new federal commission report envisions a faster, AI-driven research ecosystem with unified grant platforms, shared data, and backing for early innovators. By Allison DeAngelis Opinion: I have long Covid. Don't call my chronic disease a 'journey' There's an inherent contradiction between the dreary experience of disease and the upbeat semantics of "journey." By Peter Swenson Opinion: The hidden reason lung cancer screening is not working The lung cancer screening system is built on stigma, and it's missing too many people. It needs to change, expert writes. By Lisa Carter-Bawa

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser